CELU
Celularity IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$25.19M
P/E Ratio
—
EPS
$-3.59
Beta
0.70
52W High
$4.35
52W Low
$0.71
50-Day MA
$1.11
200-Day MA
$1.70
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Celularity Inc
Celularity Inc. is a forward-thinking biotechnology company focused on advancing regenerative medicine through its unique cellular products derived from the placenta. The company is advancing a comprehensive pipeline of innovative immunotherapies designed to provide allogeneic off-the-shelf solutions that enhance treatment effectiveness while reducing complications for cancer and other serious diseases. With a strong management team and strategic partnerships, Celularity aims to address significant unmet medical needs, positioning itself as a key player in the evolving field of advanced therapeutics.
Fundamentals
| Revenue (TTM) | $26.55M |
| Gross Profit (TTM) | $6.48M |
| EBITDA | $-54.01M |
| Operating Margin | -492.10% |
| Return on Equity | -6367.00% |
| Return on Assets | -30.90% |
| Revenue/Share (TTM) | $1.04 |
| Book Value | $-1.32 |
| Price-to-Book | 9.89 |
| Price-to-Sales (TTM) | 0.95 |
| EV/Revenue | 2.288 |
| EV/EBITDA | -36.78 |
| Quarterly Earnings Growth (YoY) | -61.30% |
| Quarterly Revenue Growth (YoY) | -77.40% |
| Shares Outstanding | $28.95M |
| Float | $18.82M |
| % Insiders | 36.41% |
| % Institutions | 12.77% |
Historical Volatility
HV 10-Day
88.70%
HV 20-Day
83.32%
HV 30-Day
70.12%
HV 60-Day
68.17%
HV Rank
—
Volatility is currently expanding
More HEALTHCARE Stocks
Data last updated: 5/25/2026